Breaking News

Research finds approach to assess Men B vaccine effectiveness

Researchers at the University of Leicester have found a new way to determine protection of Men B vaccine against ...

Cancer Research UK tests unique lung cancer vaccine

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung ...

Research hub aims to tackle the spread of new diseases

The Centre for Process Innovation will be involved in the new hub aimed at delivering high-quality vaccines at low cost, ...

Move toward cell-based manufacturing signals opening in vaccine market

Global investments and initiatives by governmental and non-governmental organisations are bringing considerable growth ...

Emergex files patent in US for novel pandemic flu vaccine

The patent, ‘Reverse Peptide Vaccines’, covers the use of peptides derived from human influenza A

Scancell receives European patent for immunotherapy platform

The developer of novel immunotherapies confirmed that the European Patent Office will grant a European Patent for its ...

Emergex receives Innovate UK Grant to progress flu vaccine

The biotechnology company, which is aiming to find a new approach to vaccine development, has received a grant to ...

GE accelerates production of viral vector based therapeutics

GE Healthcare has launched a new factory-in-a-box, designed to accelerate the manufacture of products requiring a ...

Using electrons to inactivate viruses in vaccines

Four institutes associated with the Fraunhofer Gesellschaft in Germany have been investigating new techniques to make ...

A precision medicine approach to developing cancer vaccines

Modern anticancer medicines represent a significant improvement on one-size-fits-all chemotherapy, reports Dr Sarah ...

Merck helps accelerate global access to affordable vaccines

Merck, a leading science and technology company, has announced a partnership with Oxford University’s Jenner Institute ...

Sanofi to invest €350 million in Canadian vaccine facility

Expansion demonstrates company's commitment to innovation and leadership in global public health